Skip to main content
Log in

Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases

  • Clinical Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

To evaluate the efficacy and toxicity of 5-fluorouracil (5-FU) after pars plana vitrectomy, 51 eyes were followed in a prospective and randomized clinical trial in which, upon completion of surgery, 26 eyes received 10 mg intravitreal 5-FU and 25 control eyes did not receive 5-FU. The only possible sign of 5-FU toxicity was prolonged corneal epithelial edema. Visual acuities of 20/200 or better were obtained in 67% of the 5-FU group and 56% of the control group. Successful macular reattachment was obtained in 60% of the 5-FU group and 77% of the control group. None of the eyes in either group developed substantial intraocular proliferation or membranes. The findings indicate that a single 10-mg intravitreal injection of 5-FU is well tolerated without permanent toxic damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blankenship GW, Friedland BR, Blumenkranz M (1986) Ocular effects and clearance of intravitreal 5-fluorouracil. In: Blankenship GW, Binder S, Gonvers M, Stirpe M (eds) Basic and advanced vitreous surgery. Springer, Berlin Heidelberg New York, pp 415–419

    Google Scholar 

  2. Blumenkranz MS, Ophir A, Claflin AJ, Hajek A (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467

    PubMed  Google Scholar 

  3. Blumenkranz MS, Hernandez E, Ophir A, Norton EWD (1984) 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122–130

    PubMed  Google Scholar 

  4. Blumenkranz MS, Hartzer MK, Hajek AS (1987) Selection of therapeutic agents for intraocular proliferative disease: II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol 105:396–399

    PubMed  Google Scholar 

  5. Calabresi P, Parks RE (1980) Chemotherapy of neoplastic diseases. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics, 6th edn. MacMillan, New York, pp 1249–1255

    Google Scholar 

  6. Faulborn J, Conway BP, Machemer R (1978) Surgical complications of pars plana vitreous surgery. Ophthalmology 85:116–125

    PubMed  Google Scholar 

  7. Gressel MG, Parrish RK, Folberg R (1984) 5-Fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthalmology 91:378–383

    PubMed  Google Scholar 

  8. Hatchell DL, McAdoo T, Sheta S, King RT, Bartolome JV (1988) Quantification of cellular proliferation in experimental proliferative vitreoretinopathy. Arch Ophthalmol 106:669–672

    PubMed  Google Scholar 

  9. Heuer DK, Parrish RK, Gressel MG, Hodapp E, Palmberg PF, Anderson DR (1984) 5-Fluorouracil and glaucoma filtering surgery: II. A pilot study. Ophthalmology 91:384–394

    PubMed  Google Scholar 

  10. Jarus G, Blumenkranz M, Hernandez E, Sossi N (1985) Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes. Ophthalmology 92:91–96

    PubMed  Google Scholar 

  11. Joondeph BC, Peyman GA, Khoobehi B, Yue BY (1988) Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy. Ophthalmic Surg 19:252–256

    PubMed  Google Scholar 

  12. Lewis H, Abrams GW, Williams GA (1987) Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 104:607–613

    PubMed  Google Scholar 

  13. Machemer R (1987) Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 75:556–586

    Google Scholar 

  14. Mallick KS, Hajek AS, Parrish RK (1985) Fluorouracil (5-FU) and cytarabine (Ara-C) inhibition of corneal epithelial cells and conjunctival fibrovascular proliferation. Arch Ophthalmol 103:1398–1402

    PubMed  Google Scholar 

  15. Mannis MJ, Sweet EH, Lewis RA (1988) The effect of fluorouracil on the corneal endothelium. Arch Ophthalmol 106:616–617

    Google Scholar 

  16. Orr G, Tervaert DC, Lean JS (1986) Aqueous concentrations of fluorouracil after intravitreal injection. Normal, vitrectomized, and silicone-filled eyes. Arch Ophthalmol 104:431–434

    PubMed  Google Scholar 

  17. Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121–125

    Google Scholar 

  18. Ruderman JM, Welch DB, Smith MF, Shoch DE (1987) A randomized study of 5-fluorouracil and filtration surgery. Am J Ophthalmol 104:218–224

    PubMed  Google Scholar 

  19. Sebestyen JG (1982) Fibrinoid syndrome. A severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol 14:853–856

    PubMed  Google Scholar 

  20. Stern WH, Guerin CJ (1983) Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol 96:43–51

    PubMed  Google Scholar 

  21. Vidaum-Leal JS, Glaser BM (1984) Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376–1379

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This project was supported in part by patients and contributors of the Bascom Palmer Eye Institute, Research to Prevent Blindness, Inc., New York City; Florida Lions Eye Bank Laboratory; and the Brenn Green Diabetic Retinopathy Fund, Miami, Florida

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blankenship, G.W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefe's Arch Clin Exp Ophthalmol 227, 565–568 (1989). https://doi.org/10.1007/BF02169453

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02169453

Keywords

Navigation